Publication: ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: A meta-analysis.
No Thumbnail Available
Identifiers
Date
2017-09-21
Authors
Madrid-Paredes, Adela
Cañadas-Garre, Marisa
Sánchez-Pozo, Antonio
Expósito-Ruiz, Manuela
Calleja-Hernández, Miguel Ángel
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The ABCB1 gene encodes the P-glycoprotein, an efflux pump for some antineoplastic agents which acts as a resistance mechanism to chemotherapy. Three SNPs (C3435T, C1236T and G2677T/A), are the most widely studied in ABCB1. The inconsistent conclusions about the association of these polymorphisms and the response to chemotherapy in breast cancer (BC) patients prompted us to conduct a meta-analysis. A total of nine (770 patients), five (566 patients) and three studies (367 patients) relating the ABCB1 C3435T, C1236T and G2677T/A polymorphisms respectively, were included. The main analysis revealed a lack of association between ABCB1 polymorphisms and response to chemotherapy in every genetic model: C3435T (dominant OR: 0.888; 95%CI: 0.558-1.413), C1236T (dominant OR: 1.968; 95%CI: 0.609-6.362) and G2677T/A (GG vs GT + GA + TT + TA + AA OR: 0.854; 95%CI: 0.418-1.744). Stratification by ethnicity, cancer type and response criteria did not change the pattern of results. The available evidence indicates that three polymorphisms within ABCB1; C3435T, C1236T and G2677T/A, cannot be considered a reliable predictor of response to chemotherapy in BC patients.
Description
MeSH Terms
ATP Binding Cassette Transporter, Subfamily B
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Breast Neoplasms
Female
Humans
Polymorphism, Single Nucleotide
Prognosis
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Breast Neoplasms
Female
Humans
Polymorphism, Single Nucleotide
Prognosis
DeCS Terms
CIE Terms
Keywords
ABCB1, Breast, C1236T, C3435T, Cancer, Meta-analysis